Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Finished Goods (2018 - 2025)

Historic Finished Goods for Merit Medical Systems (MMSI) over the last 11 years, with Q3 2025 value amounting to $175.9 million.

  • Merit Medical Systems' Finished Goods rose 1017.43% to $175.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $175.9 million, marking a year-over-year increase of 1017.43%. This contributed to the annual value of $168.4 million for FY2024, which is 600.66% up from last year.
  • According to the latest figures from Q3 2025, Merit Medical Systems' Finished Goods is $175.9 million, which was up 1017.43% from $170.3 million recorded in Q2 2025.
  • Merit Medical Systems' Finished Goods' 5-year high stood at $175.9 million during Q3 2025, with a 5-year trough of $104.1 million in Q2 2021.
  • Over the past 5 years, Merit Medical Systems' median Finished Goods value was $152.9 million (recorded in 2024), while the average stood at $146.0 million.
  • Its Finished Goods has fluctuated over the past 5 years, first tumbled by 1518.16% in 2021, then surged by 2739.6% in 2023.
  • Quarter analysis of 5 years shows Merit Medical Systems' Finished Goods stood at $132.4 million in 2021, then increased by 11.06% to $147.1 million in 2022, then increased by 8.05% to $158.9 million in 2023, then grew by 6.01% to $168.4 million in 2024, then rose by 4.42% to $175.9 million in 2025.
  • Its Finished Goods was $175.9 million in Q3 2025, compared to $170.3 million in Q2 2025 and $163.4 million in Q1 2025.